CureVac N.V. (CVAC)
NASDAQ: CVAC · IEX Real-Time Price · USD
3.490
+0.010 (0.29%)
May 17, 2024, 4:00 PM EDT - Market closed
CureVac Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for CureVac stock have an average target of 6.00, with a low estimate of 4.00 and a high estimate of 8.00. The average target predicts an increase of 71.92% from the current stock price of 3.49.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for CureVac stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 2 | 2 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $12 → $4 | Buy → Hold | Downgrades | $12 → $4 | +14.61% | Apr 25, 2024 |
| Guggenheim | Guggenheim | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 5, 2024 |
| B of A Securities | B of A Securities | Sell Maintains $10 → $8 | Sell | Maintains | $10 → $8 | +129.23% | Aug 21, 2023 |
| SVB Securities | SVB Securities | Buy Initiates $13 | Buy | Initiates | $13 | +272.49% | Jun 8, 2023 |
| JMP Securities | JMP Securities | Buy Maintains $34 → $24 | Buy | Maintains | $34 → $24 | +587.68% | Apr 26, 2023 |
Financial Forecast
Revenue This Year
71.91M
from 53.76M
Increased by 33.76%
Revenue Next Year
91.89M
from 71.91M
Increased by 27.79%
EPS This Year
-0.93
from -1.18
EPS Next Year
-0.74
from -0.93
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 171.2M | 253.4M | 661.1M | 538.3M | 662.8M |
| Avg | 71.9M | 91.9M | 269.9M | 237.1M | 295.0M |
| Low | n/a | 11.1M | 39.7M | 50.5M | 50.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 218.4% | 252.4% | 619.4% | 99.4% | 179.6% |
| Avg | 33.8% | 27.8% | 193.7% | -12.2% | 24.5% |
| Low | - | -84.6% | -56.8% | -81.3% | -78.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.53 | -0.18 | -0.02 | 0.86 | -0.56 |
| Avg | -0.93 | -0.74 | -0.66 | 0.16 | -0.54 |
| Low | -1.28 | -1.18 | -0.96 | -0.50 | -0.52 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.